This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Exosomes Europe
5-6 June 2024
DoubleTree Tower of London

Pierre Arsène
Founder & CEO at Mursla Bio


Pierre is the Founder and CEO of Mursla Bio, a company decoding EVs to enable curative treatments for cancer. He is also the Founder and Chair of Exosla Therapeutics, a next generation MSC-EV company to fight immune-related diseases.

He was trained in biophysics at the University of Cambridge (2020), has raised several million dollars, and holds multiple patents and publications. Prior to that, he accumulated a decade of experience in healthcare investment banking at J.P. Morgan and was involved in closing over 20 deals, totaling $70B. He earned an MSc from HEC Paris Grande Ecole (2008).

Agenda Sessions

  • The Quest for the EV 'Killer Application‘: An Exploration